Preferred Label : citrullinemia;
MeSH definition : A group of diseases related to a deficiency of the enzyme ARGININOSUCCINATE SYNTHASE
which causes an elevation of serum levels of CITRULLINE. In neonates, clinical manifestations
include lethargy, hypotonia, and SEIZURES. Milder forms also occur. Childhood and
adult forms may present with recurrent episodes of intermittent weakness, lethargy,
ATAXIA, behavioral changes, and DYSARTHRIA. (From Menkes, Textbook of Child Neurology,
5th ed, p49);
MeSH synonym : citrullinurias; deficiency disease, argininosuccinate synthase; citrullinemias; argininosuccinic acid synthase deficiency disease; argininosuccinic acid synthetase deficiency disease; citrullinuria; deficiency disease, argininosuccinic acid synthase; argininosuccinate synthase deficiency disease; Argininosuccinate Synthetase Deficiency; Argininosuccinate Synthetase Deficiencies; Deficiencies, Argininosuccinate Synthetase; Deficiency, Argininosuccinate Synthetase; Argininosuccinic Acid Synthetase Deficiency; ASS Deficiency; ASS Deficiencies; Deficiency, ASS;
CISMeF synonym : Citrullinemia 1; Deficiencies, ASS; Type 1, Citrullinemia;
MeSH hyponym : argininosuccinic acid synthetase deficiency disease, partial; argininosuccinic acid synthetase deficiency, complete; Deficiency, Argininosuccinic Acid Synthetase, Partial; Partial Argininosuccinic Acid Synthetase Deficiency Disease; Citrullinemia, Late-Onset; Citrullinemia, Late Onset; Citrullinemias, Late-Onset; Late-Onset Citrullinemia; Late-Onset Citrullinemias; Deficiency, Argininosuccinic Acid Synthetase, Complete; Complete Argininosuccinic Acid Synthetase Deficiency Disease; Citrullinemia, Classical; Citrullinemias, Classical; Classical Citrullinemia; Classical Citrullinemias; Citrullinemia, Neonatal; Citrullinemias, Neonatal; Neonatal Citrullinemia; Neonatal Citrullinemias; Citrullinemia, Type I; Type I Citrullinemia; Type I Citrullinemias; Citrullinemia Type 1; Citrullinemia, Classic; Citrullinemias, Classic; Classic Citrullinemia; Classic Citrullinemias;
Wikipedia link : https://en.wikipedia.org/wiki/Citrullinemia;
Origin ID : D020159;
UMLS CUI : C0175683;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Manual NTBT mappings (CISMeF)
ORDO relation(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- CTNL1 [MeSH Supplementary Concept]
See also
See also (suggested by CISMeF)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
A group of diseases related to a deficiency of the enzyme ARGININOSUCCINATE SYNTHASE
which causes an elevation of serum levels of CITRULLINE. In neonates, clinical manifestations
include lethargy, hypotonia, and SEIZURES. Milder forms also occur. Childhood and
adult forms may present with recurrent episodes of intermittent weakness, lethargy,
ATAXIA, behavioral changes, and DYSARTHRIA. (From Menkes, Textbook of Child Neurology,
5th ed, p49)
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=187
2014
false
France
French
citrullinemia
scientific and technical information
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=247525
2011
France
scientific and technical information
citrullinemia
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=247546
2011
France
scientific and technical information
citrullinemia
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=247573
2011
France
scientific and technical information
citrullinemia
adult
adulthood
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=247585
2011
France
scientific and technical information
citrullinemia
---
http://www.has-sante.fr/portail/display.jsp?id=c_241518
2001
France
French
antineoplastic agents
phenylbutyrates
ornithine carbamoyltransferase deficiency disease
child
carbamoyl-phosphate synthase (ammonia)
argininosuccinate synthase
citrullinemia
infant, newborn
ornithine carbamoyltransferase
infant
sodium phenylbutyrate
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid
evaluation of the transparency committee
---